NCT07894718 Effect of Ultrasound-Guided Posterior Cutaneous Nerve of the Forearm Epicondylar Branch Block on Pain and Function in Lateral Epicondylitis (PCNF-BrEpi)
| NCT ID | NCT07894718 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Gaziler Physical Medicine and Rehabilitation Education and Research Hospital |
| Condition | Lateral Epicondylitis |
| Study Type | INTERVENTIONAL |
| Enrollment | 84 participants |
| Start Date | 2025-10-25 |
| Primary Completion | 2026-12-25 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 84 participants in total. It began in 2025-10-25 with a primary completion date of 2026-12-25.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study evaluates the effect of an ultrasound-guided posterior cutaneous nerve of the forearm epicondylar branch block on pain and functional status in patients with lateral epicondylitis. The procedure is performed using ultrasound guidance. Pain and elbow function are assessed before and after the intervention to determine whether this nerve block can improve pain and functional outcomes in patients with lateral epicondylitis.
Eligibility Criteria
Inclusion Criteria: * Age between 18 and 65 years * Symptom duration of at least 6 weeks * Clinical and ultrasonographic diagnosis of lateral epicondylitis (based on history, physical examination and provocation tests) * Visual Analog Scale (VAS) pain score of 4 or higher * Signed informed consent form Exclusion Criteria: * Injection or trauma to the affected elbow region within the last 3 months * Cervical radicular pain, median or ulnar entrapment neuropathy, or medial epicondylitis * Use of anticoagulant therapy * Pregnancy or breastfeeding * Psychiatric disorder or cognitive impairment preventing completion of questionnaires and assessment scales * History of allergy to the solutions to be used (triamcinolone or lidocaine) * History of upper extremity surgery or fracture * Connective tissue disease (e.g., rheumatoid arthritis, dermatomyositis) * Diabetes mellitus, fibromyalgia, or polyneuropathy * History of active malignancy
Frequently Asked Questions
Who can join the NCT07894718 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Lateral Epicondylitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07894718 currently recruiting?
Yes, NCT07894718 is actively recruiting participants. Visit ClinicalTrials.gov or contact Gaziler Physical Medicine and Rehabilitation Education and Research Hospital to inquire about joining.
Where is the NCT07894718 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye).
Who is sponsoring the NCT07894718 clinical trial?
NCT07894718 is sponsored by Gaziler Physical Medicine and Rehabilitation Education and Research Hospital. The trial plans to enroll 84 participants.